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To investigate determinants of the public’s perceptions of 
disease threat, in 2015 we conducted a randomized survey 
experiment in the Netherlands. Adults who read a mock news 
article describing average or extreme outcomes from a hypo-
thetical influenza pandemic were more influenced by aver-
age than by extreme case information. Presenting both types 
of information simultaneously appeared counterproductive.
When pandemics strike, clear and timely communica-tion is essential to raising public awareness of dis-
ease threat and motivating preventive behaviors (1). Yet, 
in most pandemics, the experience of affected persons is 
heterogeneous: a subset of persons have severe symptoms 
or sequelae, whereas most affected persons have much 
milder symptoms or sequelae. This heterogeneity creates 
a dilemma: Should communications about new infectious 
disease threats emphasize the character and severity of 
modal cases, which represents what most persons will ex-
perience, or should they focus on the severity of extreme 
cases to make clear the potential threat, even if that threat 
is highly unlikely? Both types of information are clearly 
important. Yet, risk messages are inherently difficult to un-
derstand, and providing multiple types of information si-
multaneously might undermine the public’s understanding 
of a threat. Simplicity of message enables communications 
to stick with target audiences, and limiting communications 
to fewer, clearly contextualized, issues can increase effi-
cacy (2,3).
To begin to address this communications dilemma, 
during 2015 we conducted a randomized survey experiment 
with adult residents of the Netherlands who participate in 
an online panel administered by Survey Sampling Interna-
tional (https://www.surveysampling.com/). We established 
quotas for age and sex that approximated the distributions 
of these characteristics in the population of the Netherlands 
(online Technical Appendix, https://wwwnc.cdc.gov/EID/
article/23/4/16-1600-Techapp1.pdf). Upon completing the 
survey, participants received modest prizes.
Participants read a mock news article about a new pan-
demic (referred to as H7N3 influenza) spreading within the 
Netherlands. We randomly varied how the article discussed 
the average case severity, which was 1) not discussed, 2) 
described as mild (moderate fever and cough; generally 
goes away by itself), or 3) described as moderately severe 
(high fever, cough, vomiting; generally requires intrave-
nous medication and hospitalization). We also indepen-
dently varied the description of extreme cases, which were 
1) not discussed, 2) described as (relatively) mild (requir-
ing 1–2 days of hospitalization because of difficulty breath-
ing, dizziness, and persistent coughing), or 3) described as 
moderately severe (requiring hospitalization [and causing 
1 death] because of difficulty breathing, dizziness, severe 
coughing, and fluid in the lungs). This randomization re-
sulted in a 3 × 3 between-subjects factorial design. Follow-
ing guidelines for effective health messages (4), all articles 
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included a (fixed) efficacy message, instructing readers to 
cover their mouths for coughs and sneezes and wash hands 
frequently to prevent disease spread (online Technical Ap-
pendix). This design received exempt status approval from 
the University of Michigan Medical Institutional Review 
Board (Ann Arbor, MI, USA).
Our analyses focused on 3 questions: how much re-
spondents would worry if symptoms developed, how much 
they would worry about extreme effects if they contracted 
the disease, and participants’ vaccination intentions if a 
vaccine were available. All questions were 5-point Likert 
scales, where higher values represented greater worry or 
intent to vaccinate. Although absolute rates of concern and 
vaccination intentions are not generalizable from the hypo-
thetical scenario, significant differences among the experi-
mental conditions should be. We conducted 3 × 3 analyses 
of variance and ordered logistic regression analyses of each 
outcome with variables for each level of average and/or ex-
treme case information (not present, mild, moderate). The 
results showed close correspondence, so for simplicity we 
report only analysis of variance results.
A total of 2,695 participants completed the survey and 
answered the 3 primary outcome questions. Average age 
was 49.2 (SD ± 15.6; range 18–96) years, and 49.8% of 
respondents reported being female.
Overall, respondents were most sensitive to de-
scriptions of average case severity: worry if symptoms: 
F(2,2686) = 20.87, p<0.001; worry about extreme: 
F(2,2686) = 6.16, p = 0.002; vaccination intentions: 
F(2,2686) = 7.56, p<0.001. By contrast, the main ef-
fect of extreme case information was nonsignificant in 
all 3 analyses (0.16<p<0.77). However, we noticed evi-
dence of an interaction effect for vaccination intentions 
(F[2,2686] = 3.23, p = 0.01).
The main effect of average case information was clearly 
visible among respondents receiving no information about 
extreme cases (Table, first column). Yet, the effect of aver-
age case information appears muted (less variance) when 
extreme case descriptions were also presented. In fact, if 
participants were told that the average case was moderately 
severe (Table, bottom row), adding extreme case informa-
tion (either severity level) did not increase worry or vac-
cination intentions, and the trend is negative.
Our data suggest that information about average cases 
and extreme cases did not have additive effects on partici-
pants’ responses. We observed the strongest effects (posi-
tive and negative) of average case information when infor-
mation about extreme cases was not provided. Providing 
average case information might inhibit consideration of 
just how serious the disease could be. Average case infor-
mation also might have higher personal relevance to the 
public because extreme cases are more easily discounted. If 
so, public health communications about new threats should 
avoid presenting both types of information simultaneously.
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Table. Differences in ratings of worry and vaccination intentions compared with ratings when no information was provided about a 
hypothetical influenza pandemic, the Netherlands, 2015* 
Average case scenario 
Extreme case scenario 
No Information Mild severity Moderate severity 
No information    
 Worry if symptoms Reference –0.01 +0.20 
 Worry about extreme Reference +0.07 +0.13 
 Vaccination intentions Reference –0.16 +0.18 
Mild severity    
 Worry if symptoms –0.23 –0.08 –0.07 
 Worry about extreme –0.07 –0.01 +0.01 
 Vaccination intentions –0.25 –0.18 –0.12 
Moderate severity    
 Worry if symptoms +0.26 +0.18 +0.17 
 Worry about extreme +0.22 +0.13 +0.13 
 Vaccination intentions +0.21 +0.05 –0.06 
+, increased worry; –, decreased worry. 
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West Nile virus (WNV) infection is mainly asymptomatic 
but can be severe in elderly persons. As part of studies 
on immunity and aging in Connecticut, USA, we detected 
WNV seroconversion in 8.5% of nonimmunosuppressed 
and 16.8% of immunosuppressed persons. Age was not a 
significant seroconversion factor. Our findings suggest that 
immune factors affect seroconversion.
Since the 1999 emergence of West Nile virus (WNV) in North America, >43,000 cases of disease and 1,884 deaths 
have been reported (1); overall infections are estimated at ≈3 
million (2). Although WNV infections can be asymptomatic, 
they can also cause severe neuroinvasive disease, especially 
among infants, immunocompromised persons, and elderly 
persons (3). Control of WNV infection involves innate im-
mune pathways that mediate initial recognition and regula-
tion of viral replication and adaptive immune responses that 
provide long-term protection (3). Spatial distribution analysis 
and mosquito surveillance studies have confirmed that WNV 
is endemic to Connecticut, USA (1,4). 
We compared seroprevalence and demographics for 
890 nonimmunosuppressed and 173 immunosuppressed 
adults enrolled in a study on immunity in aging (approved 
by the Human Investigations Committee of Yale Univer-
sity) (5) with those of symptomatic WNV case-patients 
reported to the Connecticut Department of Health (DPH) 
during 2000–2014. DPH-reported symptomatic case-pa-
tients (n = 116) sought medical attention and had a positive 
WNV laboratory test result (1). None of the asymptomatic 
participants were reported to DPH as WNV case-patients. 
Immunosuppressed participants followed an immunosup-
pressive medication regimen or had a diagnosis of rheuma-
toid arthritis (5). For all participants, we assessed previous 
exposure to WNV by immunoblot for WNV envelope pro-
tein (6). Seroconversion to WNV was distinguished from 
cross-reactivity to other flaviviruses by rescreening all pos-
itive serum against a recombinant WNV-specific mutant 
envelope protein that lacks the conserved cross-reactive 
fusion loop epitope (7). 
We compared demographic characteristics of partici-
pant groups by using the Student t-test for continuous vari-
ables and χ2 and Fisher exact tests for categorical variables; 
p<0.05 indicated statistical significance. Analysis was 
completed with SAS software version 9.3 (SAS Institute, 
Cary, NC, USA) and Prism 6 (GraphPad Software, Inc., La 
Jolla, CA, USA).
Immunoblot detected evidence of WNV exposure in 
76 (8.5%) of the 890 nonimmunosuppressed participants 
(Table). These seropositive participants reported neither 
symptoms nor diagnosis of WNV infection and are con-
sidered to have had asymptomatic infections. Timing of 
asymptomatic infections could not be determined, but anti-
bodies against WNV are durable and do not differ between 
asymptomatic and symptomatic adults (8).
Although age is a critical risk factor for severe WNV 
infection (3,9), the mean age of seropositive and seronega-
tive nonimmunosuppressed participants did not differ sig-
nificantly (Table). The rate of asymptomatic seroconver-
sion did not vary significantly among the 890 persons in 3 
age groups: <35 years (42/421), 35–65 years (7/121), and 
>65 years (27/348) (p = 0.338). Seroconversion rates did 
not differ significantly by patient sex but were significantly 
elevated among those in self-identified Hispanic groups 
(p<0.0001), possibly because of different exposure histo-
ries. The similar age distribution among asymptomatic se-
roconverters suggests that the observed age-associated sus-
ceptibility to clinically apparent disease may result from 
other factors, including individual host factors and dysreg-
ulation in immune responses (6,10).
Among 173 immunosuppressed adults, 29 (16.8%) 
showed evidence of exposure to WNV (Table), resulting in 
2.16 times the odds of positive immunoblot result than for 
nonimmunosuppressed adults (76/890, 8.5%; p = 0.002). 
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